The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

DURHAM, N.C. and FRANKFURT, Germany, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world's largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical ...

The collaboration between Parexel and Partex is designed to leverage artificial intelligence-powered solutions to accelerate drug discovery and development. Parexel, a clinical research organization ...

(RTTNews) - Partex NV and Fortress Biotech, Inc. (FBIO) have entered into a strategic collaboration aimed at accelerating the identification and evaluation of biopharmaceutical assets using Partex's ...

Global CRO Parexel will partner with Partex to leverage AI and other advanced technologies to help streamline clinical trials and boost the discovery and development of new and existing therapies.

The private sector is a well-suited channel for the top biopharma to conduct more efficient clinical trials with easier and faster access to investigators and patients, a recent report revealed.

Clinical research organisation Parexel and Partex have announced a collaboration to leverage artificial intelligence-driven solutions to accelerate drug discovery and development for biopharmaceutical ...

The 78-year-old was admitted to the Evercare Hospital in Dhaka on Dec 11 after testing positive for coronavirus. Doctors put him on life support on Dec 16 after his health deteriorated. Russell said ...

Lucknow: Multi-country-based digital pharma company Partex has expressed the desire to make an investment of about Rs 1000 crore in Uttar Pradesh. Founder and CEO of the company Dr Gunjan Bharadwaj ...

Partex Group, one of the largest family-owned manufacturing and service-based companies in Bangladesh, has split its business into two groups to improve management procedures. Sultana Hashem, wife of ...

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for ...